Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects

阿格列汀 耐受性 药代动力学 二肽基肽酶-4抑制剂 二甲双胍 交叉研究 药理学 医学 加药 曲线下面积 内科学 不利影响 2型糖尿病 内分泌学 糖尿病 安慰剂 替代医学 病理 磷酸西他列汀
作者
Aziz Karim,Paul S. Covington,Rita Christopher,Michael Davenport,P. Fleck,X. Li,Elisabeth R. Wann,Qais Mekki
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics [Dustri-Verlag]
卷期号:48 (01): 46-58 被引量:37
标识
DOI:10.5414/cpp48046
摘要

OBJECTIVE: The dipeptidyl peptidase-4 inhibitor alogliptin, under development for treatment of Type 2 diabetes, primarily is excreted renally. This study investigated (1) the effect of food on alogliptin pharmacokinetics and tolerability and (2) pharmacokinetic interactions between alogliptin and metformin or cimetidine and tolerability of alogliptin when administered with either drug. METHODS: This randomized, open-label, two-phase, crossover study recruited healthy adults. In the single-dose phase, 36 subjects received an oral dose of alogliptin 100 mg under fed or fasted conditions. In the multiple-dose phase, subjects in one arm (n = 17) received 6 days each of alogliptin 100 mg once daily (q.d.), metformin 1,000 mg twice daily (b.i.d), and alogliptin q.d. + metformin b.i.d; subjects in the other arm (n = 18) received 6 days each of alogliptin 100 mg q.d., cimetidine 400 mg q.d., and alogliptin q.d. + cimetidine b.i.d. Pharmacokinetic parameters were determined after the last dose in each period. Tolerability was assessed through adverse events and clinical findings. RESULTS: Food had no effect on alogliptin area under the concentration-time curve (AUC) from 0 h to infinity and a small, clinically insignificant effect on maximum plasma concentration (C(max)) (fed/fasted least squares (LS) geometric mean ratio, 0.856; 90% confidence interval (CI), 0.798 - 0.917). Metformin and cimetidine did not affect alogliptin pharmacokinetics. Alogliptin had no effect on metformin C(max) and a small, clinically insignificant effect on AUC over the dosing interval ((alogliptin + metformin)/metformin LS geometric mean ratio, 1.19; 90% CI, 1.095 - 1.291). Alogliptin did not affect cimetidine pharmacokinetics. Alogliptin tolerability was similar under all conditions. CONCLUSION: Alogliptin can be administered without regard to meals and with metformin or cimetidine without the need for dose adjustment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
蠢宝贝完成签到,获得积分10
2秒前
陈永伟完成签到,获得积分0
5秒前
5秒前
ffiu完成签到,获得积分10
6秒前
yigemutouren发布了新的文献求助10
6秒前
小杨爱晒太阳完成签到 ,获得积分10
8秒前
zxp完成签到,获得积分10
8秒前
寒冷梦凡完成签到,获得积分10
8秒前
YUJIALING发布了新的文献求助10
9秒前
Hello应助科研通管家采纳,获得10
10秒前
烟花应助科研通管家采纳,获得10
10秒前
10秒前
小二郎应助科研通管家采纳,获得20
10秒前
NexusExplorer应助科研通管家采纳,获得10
10秒前
搜集达人应助科研通管家采纳,获得10
10秒前
10秒前
cdercder应助科研通管家采纳,获得10
10秒前
无花果应助科研通管家采纳,获得30
10秒前
Sixy完成签到 ,获得积分10
10秒前
NexusExplorer应助科研通管家采纳,获得10
10秒前
OK应助科研通管家采纳,获得20
10秒前
英俊的铭应助科研通管家采纳,获得10
11秒前
华仔应助科研通管家采纳,获得10
11秒前
科研啦应助科研通管家采纳,获得10
11秒前
饱满含玉完成签到,获得积分10
11秒前
11秒前
英俊的铭应助科研通管家采纳,获得10
11秒前
慕青应助寒冷梦凡采纳,获得10
11秒前
藤藤菜应助科研通管家采纳,获得10
11秒前
藤藤菜应助科研通管家采纳,获得10
11秒前
精明钻石应助科研通管家采纳,获得60
11秒前
深情安青应助科研通管家采纳,获得10
11秒前
NexusExplorer应助科研通管家采纳,获得10
11秒前
JamesPei应助yigemutouren采纳,获得10
12秒前
12秒前
12秒前
丘比特应助科研通管家采纳,获得10
12秒前
bkagyin应助yigemutouren采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Organic Chemistry, 5th Edition 1000
Nondestructive Testing Handbook: Vol. 4, Thermal and Infrared Testing (IR), 4th ed 800
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 590
Évora na Idade Média 555
Soil mites of the family Rhagidiidae (Actinedida: Eupodoidea). Morphology, Systematics, Ecology 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7371238
求助须知:如何正确求助?哪些是违规求助? 8978852
关于积分的说明 19088752
捐赠科研通 7013222
什么是DOI,文献DOI怎么找? 3225034
关于科研通互助平台的介绍 2388657
邀请新用户注册赠送积分活动 2205731